Terms: = Kidney tumors AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Treatment
476 results:
1. Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas.
Roskoski R
Pharmacol Res; 2024 May; 203():107181. PubMed ID: 38614375
[TBL] [Abstract] [Full Text] [Related]
2. Predictive factors of bladder tumor recurrence after radical treatment of upper urinary tract cancer.
Ouanes Y; Chaker K; Yaich S; Foued D; Marrak M; Nouira Y
Tunis Med; 2023 Mar; 101(3):356-361. PubMed ID: 38263921
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Hyperglycemia on Complication and Mortality after Transarterial Chemoembolization for Hepatocellular Carcinoma.
Moon SJ; Ahn CH; Lee YB; Cho YM
Diabetes Metab J; 2024 Mar; 48(2):302-311. PubMed ID: 38171144
[TBL] [Abstract] [Full Text] [Related]
4. Percutaneous ablation of renal tumors: Long-term outcomes.
Del Cura Rodríguez JL; Zabala-Landa R; Korta-Gomez I
Radiologia (Engl Ed); 2023; 65(6):492-501. PubMed ID: 38049248
[TBL] [Abstract] [Full Text] [Related]
5. Cardiorespiratory fitness and BMI measured in youth and 5-year mortality after site-specific cancer diagnoses in men-A population-based cohort study with register linkage.
Onerup A; Mehlig K; Ekblom-Bak E; Lissner L; Börjesson M; Åberg M
Cancer Med; 2023 Oct; 12(19):20000-20014. PubMed ID: 37732468
[TBL] [Abstract] [Full Text] [Related]
6. Impact of the COVID-19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group study.
Roy P; van Peer SE; Dandis R; Duncan C; de Aguirre-Neto JC; Verschuur A; de Camargo B; Karim-Kos HE; Boschetti L; Spreafico F; Ramirez-Villar GL; Graf N; van Tinteren H; Pritchard-Jones K; van den Heuvel-Eibrink MM
Cancer Med; 2023 Aug; 12(16):17098-17111. PubMed ID: 37496317
[TBL] [Abstract] [Full Text] [Related]
7. kidney and Cancer Outcomes with Standard Versus Alternative Chemotherapy Regimens for First-Line treatment of Metastatic Urothelial Carcinoma.
Côté G; Alqaisi H; Chan CT; Jiang DM; Kandel C; Pelletier K; Wald R; Sridhar SS; Kitchlu A
Kidney360; 2023 Sep; 4(9):e1203-e1211. PubMed ID: 37461133
[TBL] [Abstract] [Full Text] [Related]
8. The prognostic role of cigarette smoking in kidney Cancer Survival.
Baral A; Cranford HM; Sharma J; Pinheiro PS
Cancer Med; 2023 Jul; 12(13):14756-14766. PubMed ID: 37199389
[TBL] [Abstract] [Full Text] [Related]
9. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta AR; Ballas LK; Niemierko A; Lajkosz K; Kuk C; Miranda G; Drumm M; Mari A; Thio E; Fleshner NE; Kulkarni GS; Jewett MAS; Bristow RG; Catton C; Berlin A; Sridhar SS; Schuckman A; Feldman AS; Wszolek M; Dahl DM; Lee RJ; Saylor PJ; Michaelson MD; Miyamoto DT; Zietman A; Shipley W; Chung P; Daneshmand S; Efstathiou JA
Lancet Oncol; 2023 Jun; 24(6):669-681. PubMed ID: 37187202
[TBL] [Abstract] [Full Text] [Related]
10. [Second and further lines treatment options for locally advanced or metastatic renal cell carcinoma].
Nagyiványi K; Géczi L
Magy Onkol; 2023 Apr; 67(1):61-72. PubMed ID: 37086459
[TBL] [Abstract] [Full Text] [Related]
11. Urinary Neuroendocrine Neoplasms Treated in the "Modern Era": A Multicenter Retrospective Review.
Le BK; McGarrah P; Paciorek A; Mohamed A; Apolo AB; Chan DL; Reidy-Lagunes D; Hauser H; Rivero JD; Whitman J; Batty K; Zhang L; Raj N; Le T; Bergsland E; Halfdanarson TR
Clin Genitourin Cancer; 2023 Jun; 21(3):403-414.e5. PubMed ID: 37031047
[TBL] [Abstract] [Full Text] [Related]
12. Variant histology in upper tract carcinomas: Analysis of the National Cancer Database.
Song E; Suek T; Davaro F; Hamilton Z
Urol Oncol; 2023 Apr; 41(4):206.e1-206.e9. PubMed ID: 36822992
[TBL] [Abstract] [Full Text] [Related]
13. Trends in Survival and Surgical Methods in Patients Surgically Treated for Metastatic Spinal tumors: 25-Year Experience in a Single Institution.
Park SJ; Park JS; Lee CS; Kang BJ; Jung CW
Clin Orthop Surg; 2023 Feb; 15(1):109-117. PubMed ID: 36778984
[TBL] [Abstract] [Full Text] [Related]
14. Associations of age, BMI, and renal function to cortisol after dexamethasone suppression in patients with adrenal incidentalomas.
Olsen H; Olsen M
Front Endocrinol (Lausanne); 2022; 13():1055298. PubMed ID: 36760812
[TBL] [Abstract] [Full Text] [Related]
15. Purely Off-Clamp Laparoscopic Partial Nephrectomy Stands the Test of Time: 15 Years Functional and Oncologic Outcomes from a Single Center Experience.
Brassetti A; Anceschi U; Bove AM; Prata F; Costantini M; Ferriero M; Mastroianni R; Misuraca L; Tuderti G; Torregiani G; Covotta M; Gallucci M; Simone G
Curr Oncol; 2023 Jan; 30(1):1196-1205. PubMed ID: 36661741
[TBL] [Abstract] [Full Text] [Related]
16. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis.
Massicotte-Azarniouch D; Detwiler RK; Hu Y; Falk RJ; Saha MK; Hogan SL; Derebail VK
Nephrol Dial Transplant; 2023 Aug; 38(9):2009-2018. PubMed ID: 36549661
[TBL] [Abstract] [Full Text] [Related]
17. Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish kidney Cancer Register.
Almdalal T; Karlsson Rosenblad A; Hellström M; Kjellman A; Lindblad P; Lundstam S; Sundqvist P; Ljungberg B
Scand J Urol; 2023; 57(1-6):67-74. PubMed ID: 36520023
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative risk factors associated with anastomotic leakage after colectomy for colorectal cancer: a systematic review and meta-analysis.
Dias VE; Castro PASV; Padilha HT; Pillar LV; Godinho LBR; Tinoco ACA; Amil RDC; Soares AN; Cruz GMGD; Bezerra JMT; Silva TAMD
Rev Col Bras Cir; 2022; 49():e20223363. PubMed ID: 36449942
[TBL] [Abstract] [Full Text] [Related]
19. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.
Kim SH; Park J; Park WS; Hong D; Chung J
Investig Clin Urol; 2022 Nov; 63(6):602-611. PubMed ID: 36347549
[TBL] [Abstract] [Full Text] [Related]
20. Analysis and Prediction of the Survival Trends of Patients with Clear-Cell Renal Cell Carcinoma: A Model-Based Period Analysis, 2001-2015.
Du S; Zhong Y; Zheng S; Lyu J
Cancer Control; 2022; 29():10732748221121226. PubMed ID: 35981235
[TBL] [Abstract] [Full Text] [Related]
[Next]
